Download
Download by
Scanning QR Code
  • Download app

    Download app

  • Online Inquiry

    Log in to access Online Inquiry
+
Congratulations
You've successfully got advanced quotes worth 5000 HKD
Download APP >>
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Futubull > Quotes > PRTG Portage Biotech > Detailed Quotes

PRTG Portage Biotech

Watchlist
7.090
+0.110+1.58%
Close 07/01 16:00 ET
Giving away premium quotes worth 5000 HKD/year to unlock more data
Get NOW
High
7.320
Open
7.050
Turnover
204.31K
Low
6.960
Pre Close
6.980
Volume
28.68K
Market Cap
94.62M
P/E(TTM)
Loss
52wk High
23.990
Shares
13.35M
P/E(Static)
Loss
52wk Low
4.620
Float Cap
32.29M
Bid/Ask %
-100.00%
Historical High
44.976
Shs Float
4.55M
Volume Ratio
0.22
Historical Low
4.620
Dividend TTM
--
Div Yield TTM
--
P/B
0.75
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
0.63%
Amplitude
5.16%
Avg Price
7.123
Lot Size
1
Float Cap
32.29M
Bid/Ask %
-100.00%
Historical High
44.976
Shs Float
4.55M
Volume Ratio
0.22
Historical Low
4.620
Dividend TTM
--
P/B
0.75
Dividend LFY
--
Turnover Ratio
0.63%
Amplitude
5.16%
Avg Price
7.123
Lot Size
1
Price Forecast

No Data

News

Comment

Company Overview More
Portage Biotech Inc., together with its subsidiaries, researches and develops pharmaceutical and biotechnology products. The company’s product includes IMM60, an iNKT cell activator; IMM65, a PLGA-nanoparticle combined with a NY-ESO-1 peptide vaccine; INT230-6 that is in Phase I/II clinical trials for the treatment of solid tumors; STING, a small molecule that binds to the stimulator of interferon genes in cancer; CellPorter, a cell permeable peptide platform technology derived from human proteins; PPL-003, an ophthalmic solution; and SBI-101, a blood-conditioning technology to restore balance to the immune system after acute vital organ injury, such as acute kidney injury. It also focuses on nanolipogel technology for use in immune-oncology; and antibodies against a novel T-cell for use as a monotherapy and combination therapy for solid and haematological malignancies. In addition, the company develops antibodies implicated in the inflammatory tumor and tumor-infiltrating immune cell microenvironments; and FOXO4-P53 modulator and C-RAF inhibitor. Portage Biotech Inc. is based in Tortola, British Virgin Islands.
CEO: Walters M.B.A., M.D., Ian B.
Market: NASDAQ
Futu Hot List
USHKCN
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist
Back to the Top